お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:世界の前立腺癌治療薬の市場規模調査:治療法別、流通経路別、および地域別予測(2020年~2027年)
市場調査レポート
商品コード
971931

世界の前立腺癌治療薬の市場規模調査:治療法別、流通経路別、および地域別予測(2020年~2027年)

Global Prostate Cancer Therapeutics Market Size study, By Therapy and By Distribution Channel, and Regional Forecasts 2020-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=112.06円
世界の前立腺癌治療薬の市場規模調査:治療法別、流通経路別、および地域別予測(2020年~2027年)
出版日: 2020年10月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の前立腺癌治療薬の市場規模は2019年に約99億米ドルであり、2020年から2027年の予測期間にわたって7.68%を超える成長率で成長すると予想されています。前立腺がんの正確な原因は不明ですが、それに関連する要因には、太りすぎ、肥満、およびその他の腫瘍増殖の病歴が含まれます。そして、心血管疾患の患者は癌転移に対して脆弱です。その結果、上記の条件の発生率の上昇は、市場の成長を推進しています。さらに、市場のプレーヤーは、腫瘍の治療のための治療薬を開発するための調査に投資しています。さらに、主要な既存製品の特許の満了により、多くのジェネリック製品が予測期間中に市場に出ると予想されます。結果として、これらの要因が成長を促進すると予想されます。

当レポートでは、前立腺癌治療薬市場を調査し、市場概要、市場の成長要因および阻害要因の分析、治療法別、流通経路別、地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の前立腺癌治療薬市場の定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査範囲
    • 業界の進化
  • 調査対象年度
  • 為替レート

第3章 世界の前立腺癌治療薬:市場力学

  • 前立腺癌治療薬市場の影響分析

第4章 世界の前立腺癌治療薬市場:業界分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 世界の前立腺癌治療薬市場:治療法別

  • 市場スナップショット
  • 世界の前立腺癌治療薬市場-潜在的な分析
  • 世界の前立腺癌治療薬市場:推定と予測
  • 前立腺癌治療薬市場:サブセグメント分析
    • ホルモン療法
    • 標的療法
    • 化学療法
    • 生物学的療法

第6章 世界の前立腺癌治療薬市場:流通チャネル別

  • 市場スナップショット
  • 世界の前立腺癌治療薬市場-潜在的な分析
  • 世界の前立腺癌治療薬市場:推定と予測
  • 前立腺癌治療薬市場:サブセグメント分析
    • 病院薬局
    • オンライン販売
    • 小売薬局
    • その他

第7章 世界の前立腺癌治療薬市場:地域別分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Bayer AG
    • Johnson & Johnson
    • Ipsen Group
    • Amgen, Inc.
    • Endo Pharmaceuticals, Inc.
    • AbbVie, Inc.
    • Pfizer, Inc.
    • AstraZeneca
    • Sanofi
    • Sanpower Group

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, REPORT SCOPE
  • TABLE 2. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
  • TABLE 3. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY THERAPY 2017-2027 (USD BILLION)
  • TABLE 4. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2017-2027 (USD BILLION)
  • TABLE 5. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 6. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 7. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 8. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 9. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 10. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 11. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 12. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 13. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 14. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 15. U.S. PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 16. U.S. PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 17. U.S. PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 18. CANADA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 19. CANADA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 20. CANADA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 21. UK PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 22. UK PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 23. UK PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 24. GERMANY PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 25. GERMANY PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 26. GERMANY PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 27. ROE PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 28. ROE PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 29. ROE PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 30. CHINA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 31. CHINA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 32. CHINA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 33. INDIA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 34. INDIA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 35. INDIA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 36. JAPAN PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 37. JAPAN PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 38. JAPAN PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 39. ROAPAC PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 40. ROAPAC PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 41. ROAPAC PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 42. BRAZIL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 43. BRAZIL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 44. BRAZIL PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 45. MEXICO PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 46. MEXICO PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 47. MEXICO PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 48. ROLA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 49. ROLA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 50. ROLA PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 51. ROW PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 52. ROW PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 53. ROW PROSTATE CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 54. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL PROSTATE CANCER THERAPEUTICS MARKET
  • TABLE 55. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL PROSTATE CANCER THERAPEUTICS MARKET
  • TABLE 56. YEARS CONSIDERED FOR THE STUDY
  • TABLE 57. EXCHANGE RATES CONSIDERED

LIST OF FIGURES

  • FIG 1. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, GROWTH PROSPECTS 2020-2027
  • FIG 6. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 10. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 11. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 12. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 13. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 14. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, REGIONAL SNAPSHOT 2017 & 2027
  • FIG 15. NORTH AMERICA PROSTATE CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 16. EUROPE PROSTATE CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 17. ASIA PACIFIC PROSTATE CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 18. LATIN AMERICA PROSTATE CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 19. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
目次

Title:
Global Prostate Cancer Therapeutics Market Size study, By Therapy (Hormone Therapy, Targeted Therapy, Chemotherapy, and Biologic Therapy) and By Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, and Others), and Regional Forecasts 2020-2027.

Global Prostate Cancer Therapeutics Market is valued approximately at USD 9.9 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.68% over the forecast period 2020-2027. According to data released by the World Cancer Research Fund International, more than 1.1 million cases of prostate cancer have been registered in 2012, accounting for around 8 percent of the total tumor cases. Although the exact cause of prostate cancer is not known, the factors associated with it include overweight, obesity, and the history of any other tumor growth. And patients with cardiovascular disease are vulnerable to cancer metastases. As a result, the rising incidence rate of the above-mentioned conditions is driving market growth. The introduction of emerging technologies in screening and diagnostic tests is expected to drive development. The integration of multiparametric MRI (mp-MRI) will greatly enhance tumor detection and also validate the need for tissue biopsy. In addition, market players are investing in research to develop therapeutic drugs for the treatment of such tumors. For example, there is a strong pipeline of products such as Tc-99 m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in phase 3 studies and are expected to enter the market in the near future. In addition, due to the expiry of the patents of the major existing products, many generic products are expected to reach the market during the forecast period. As a result, these factors are expected to drive growth. In addition to screening and diagnostic testing, recognition of the availability of drugs to the public is also of the utmost importance to break down the social stigma associated with tumor therapy and to enable patients to be offered prompt care. Governments in developing countries are making efforts to undertake and introduce programs to raise awareness of screening tests, such as Prostate-specific antigen (PSA) blood tests and Digital Rectal Exam (DRE) for male patients over 50 years of age. Prostate Cancer Canada has been founded to promote research, care and prevention of prostate cancer. Such awareness campaigns are also being introduced in developing countries such as China, India and Brazil.

The regional analysis of global Prostate Cancer Therapeutics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is expected to dominate the market share over the forecast period (2020-2027). Rising prevalence and high mortality rates of prostate cancer in the U.S. are the primary reasons for North America 's market supremacy. In addition, this region is experiencing a high level of investment in R&D to develop newer immunotherapy and targeted drug therapies to treat these tumors.

Major market player included in this report are:

  • Bayer AG
  • Johnson & Johnson
  • Ipsen Group
  • Amgen, Inc.
  • Endo Pharmaceuticals, Inc.
  • AbbVie, Inc.
  • Pfizer, Inc.
  • AstraZeneca
  • Sanofi
  • Sanpower Group

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

  • Hormone Therapy
  • Targeted Therapy
  • Chemotherapy
  • Biologic Therapy

By Distribution Channel:

  • Hospital Pharmacies
  • Online Sales
  • Retail Pharmacies
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2017, 2018
  • Base year - 2019
  • Forecast period - 2020 to 2027

Target Audience of the Global Prostate Cancer Therapeutics Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Prostate Cancer Therapeutics Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Prostate Cancer Therapeutics Market, by Therapy, 2018-2027 (USD Billion)
    • 1.2.3. Prostate Cancer Therapeutics Market, by Distribution Channel, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Prostate Cancer Therapeutics Market Definition & Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Prostate Cancer Therapeutics Market Dynamics

  • 3.1. Prostate Cancer Therapeutics Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Prostate Cancer Therapeutics Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Prostate Cancer Therapeutics Market, by Therapy

  • 5.1. Market Snapshot
  • 5.2. Global Prostate Cancer Therapeutics Market by Therapy, Performance - Potential Analysis
  • 5.3. Global Prostate Cancer Therapeutics Market Estimates & Forecasts by Therapy, 2017-2027 (USD Billion)
  • 5.4. Prostate Cancer Therapeutics Market, Sub Segment Analysis
    • 5.4.1. Hormone Therapy
    • 5.4.2. Targeted Therapy
    • 5.4.3. Chemotherapy
    • 5.4.4. Biologic Therapy

Chapter 6. Global Prostate Cancer Therapeutics Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Prostate Cancer Therapeutics Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Prostate Cancer Therapeutics Market Estimates & Forecasts by Distribution Channel, 2017-2027 (USD Billion)
  • 6.4. Prostate Cancer Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. Online Sales
    • 6.4.3. Retail Pharmacies
    • 6.4.4. Others

Chapter 7. Global Prostate Cancer Therapeutics Market, Regional Analysis

  • 7.1. Prostate Cancer Therapeutics Market, Regional Market Snapshot
  • 7.2. North America Prostate Cancer Therapeutics Market
    • 7.2.1. U.S. Prostate Cancer Therapeutics Market
      • 7.2.1.1. Therapy breakdown estimates & forecasts, 2017-2027
      • 7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
    • 7.2.2. Canada Prostate Cancer Therapeutics Market
  • 7.3. Europe Prostate Cancer Therapeutics Market Snapshot
    • 7.3.1. U.K. Prostate Cancer Therapeutics Market
    • 7.3.2. Germany Prostate Cancer Therapeutics Market
    • 7.3.3. France Prostate Cancer Therapeutics Market
    • 7.3.4. Spain Prostate Cancer Therapeutics Market
    • 7.3.5. Italy Prostate Cancer Therapeutics Market
    • 7.3.6. Rest of Europe Prostate Cancer Therapeutics Market
  • 7.4. Asia-Pacific Prostate Cancer Therapeutics Market Snapshot
    • 7.4.1. China Prostate Cancer Therapeutics Market
    • 7.4.2. India Prostate Cancer Therapeutics Market
    • 7.4.3. Japan Prostate Cancer Therapeutics Market
    • 7.4.4. Australia Prostate Cancer Therapeutics Market
    • 7.4.5. South Korea Prostate Cancer Therapeutics Market
    • 7.4.6. Rest of Asia Pacific Prostate Cancer Therapeutics Market
  • 7.5. Latin America Prostate Cancer Therapeutics Market Snapshot
    • 7.5.1. Brazil Prostate Cancer Therapeutics Market
    • 7.5.2. Mexico Prostate Cancer Therapeutics Market
  • 7.6. Rest of The World Prostate Cancer Therapeutics Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Bayer AG
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Industry Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Johnson & Johnson
    • 8.2.3. Ipsen Group
    • 8.2.4. Amgen, Inc.
    • 8.2.5. Endo Pharmaceuticals, Inc.
    • 8.2.6. AbbVie, Inc.
    • 8.2.7. Pfizer, Inc.
    • 8.2.8. AstraZeneca
    • 8.2.9. Sanofi
    • 8.2.10. Sanpower Group

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.